Our studies ultimately demonstrate that SIRT1 plays an important role in the regulation of mitochondrial biogenesis through the PGC-1α-TFAM pathway, and SIRT1 may represent a potential target for therapeutic intervention in prion diseases. This evidence concerns the gene TFAM and prion disease.